This question is part of our collaboration with ASTRO 2025 to highlight impactful trial data from this year's meeting. This question is inspired by the Plenary Session Presentation "Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial: Health-Related Quality Of Life Outcomes" by Dr. Shannon MacDonald.
I concur. When one evaluates modern radiotherapy u...
I agree with @Chirag S. Shah and @Jonathan B. Stra...
@Imran Zoberi good point. I do strongly believe in...
Agreed. We use RT commonly for RT-induced angiosar...